Prospectively Planned Analysis of Data From a Phase III Study of Liposomal Muramyltripeptide Phosphatidylethanolamine in the Treatment of Osteosarcoma

Authors :: Jean-Loup Romet-Lemonne
Bonnie Mills
Wolf Hervé Fridman
Mark F. Munsell
Source :: Journal of Clinical Oncology. 23:6437-6438
Publication Year :: 2005
Publisher :: American Society of Clinical Oncology (ASCO), 2005.

Subjects :: Phosphatidylethanolamine
Oncology
Cancer Research
medicine.medical_specialty
Liposome
business.industry
Treatment outcome
medicine.disease
Surgery
chemistry.chemical_compound
chemistry
Internal medicine
Maximum tolerated dose
Medicine
Osteosarcoma
Neoplasm staging
business
Prospective cohort study

Tools